Physician profile
Patrick J Sweeney
NPI 1174533228
$2,592.12
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $184 · 2021: $635 · 2022: $93.96 · 2023: $526 · 2024: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.43 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $855.90 | 2019-2024 | Xtandi |
| Pfizer INC. | $243.92 | 2019-2023 | |
| Boston Scientific Corporation | $172.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $132.73 | 2021-2024 | Lynparza |
| Janssen Biotech, INC. | $124.56 | 2019-2023 | Erleada |
| Coloplast Corp | $111.79 | 2021-2023 | Speedicath |
| Dendreon Pharmaceuticals LLC | $101.24 | 2019-2024 | Provenge |
| Abbvie INC. | $98.50 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $53.50 | 2021-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $52.53 | 2023-2024 | Pylarify |
| Antares Pharma, INC. | $51.55 | 2021 | |
| Amgen INC. | $48.75 | 2019-2022 | |
| Olympus America INC. | $40.17 | 2019-2023 | Itind System |
| Laborie Medical Technologies Corp. | $38.85 | 2021-2024 | Endosheath Technology |
| Medtronic, INC. | $38.32 | 2023-2024 | Interstim |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $36.38 | 2023 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $36.12 | 2019-2024 | Adstiladrin |
| Axonics, INC. | $30.51 | 2022-2023 | Axonics |
| Endo Pharmaceuticals INC. | $30.37 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $28.59 | 2020 | |
| Henry Schein, INC. | $24.13 | 2024 | |
| Cook Medical LLC | $23.74 | 2019 | |
| Teleflex LLC | $23.31 | 2021 | |
| Merck Sharp & Dohme LLC | $21.91 | 2021 | |
| Blue Earth Diagnostics | $20.50 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.02 | 2024 | |
| Ethicon US, LLC | $19.91 | 2019 | |
| Myovant Sciences INC. | $18.81 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.04 | 2020 | |
| Urogen Pharma, INC. | $15.89 | 2021 | |
| Urovant Sciences INC | $15.68 | 2021 | |
| Medtronic USA, INC. | $15.66 | 2019 | |
| Foundation Medicine, INC. | $15.44 | 2023 | Foundationone Liquid Cdx |
| Neotract INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.